Tumor cell nuclear diameter and CD30 expression as potential prognostic parameter in patients with extranodal NK/T-cell lymphoma, nasal type

International Journal of Clinical and Experimental Pathology

Volumn 5, Issue 9, 2012, Pages 939-947

  Hong, Junshik ^a   Park, Sanghui ^b   Baek, Hae Lim ^a   Jung, Joo Hyun ^c   Kang, Il Gyu ^c   Sym, Sun Jin ^a   Park, Jinny ^a   Ahn, Jeong Yeal ^a   Cho, Eun Kyung ^a   Kim, Seon Tae ^c   Shin, Dong Bok ^a   Lee, Jae Hoon ^a  

^a Gachon University   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

^c Department of Otorhinolaryngology Head and Neck Surgery ^*  (South Korea)

Author keywords

CD30; Epstein barr virus; Extranodal NK T cell lymphoma; Nasal type; Nuclear diameter; Prognosis

Indexed keywords

CD30 ANTIGEN; TUMOR MARKER; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; EPSTEIN BARR VIRUS; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IN SITU HYBRIDIZATION; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NK T CELL LYMPHOMA; NUCLEAR SIZE; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD30; BIOPSY; CELL NUCLEUS SIZE; DISEASE-FREE SURVIVAL; DNA, VIRAL; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KAPLAN-MEIER ESTIMATE; LYMPHOMA, EXTRANODAL NK-T-CELL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84870414340     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Aozasa K, Ohsawa M, Tajima K, Sasaki R, Maeda H, Matsunaga T and Friedmann I. Nationwide study of lethal mid-line granuloma in Japan: frequencies of wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions. Int J Cancer 1989; 44: 63-66.
2. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA and Bloomfield CD. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835-3849.
3. Jaffe ES, Chan JK, Su IJ, Frizzera G, Mori S, Feller AC and Ho FC. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996; 20: 103-111.
4. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW and editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue (IARC WHO Classification of Tumours). Lyon: IARC Press; 2008.
5. Kim GE, Cho JH, Yang WI, Chung EJ, Suh CO, Park KR, Hong WP, Park IY, Hahn JS, Roh JK and Kim BS. Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. J Clin Oncol 2000; 18: 54-63.
6. Lee J, Park YH, Kim WS, Lee SS, Ryoo BY, Yang SH, Park KW, Kang JH, Park JO, Lee SH, Kim K, Jung CW, Park YS, Im YH, Kang WK, Lee MH, Ko YH, Ahn YC and Park K. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy. Eur J Cancer 2005; 41: 1402-1408.
7. Kim TM, Park YH, Lee SY, Kim JH, Kim DW, Im SA, Kim TY, Kim CW, Heo DS, Bang YJ, Chang KH and Kim NK. Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type. Blood 2005; 106: 3785-3790.
8. Lee J, Suh C, Park YH, Ko YH, Bang SM, Lee JH, Lee DH, Huh J, Oh SY, Kwon HC, Kim HJ, Lee SI, Kim JH, Park J, Oh SJ, Kim K, Jung C, Park K and Kim WS. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 2006; 24: 612-618.
9. Kuo TT, Shih LY and Tsang NM. Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities. Int J Surg Pathol 2004; 12: 375-387.
10. Quintanilla-Martinez L, Kremer M, Keller G, Nathrath M, Gamboa-Dominguez A, Meneses A, Luna-Contreras L, Cabras A, Hoefler H, Mohar A and Fend F. p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease. Am J Pathol 2001; 159: 2095-2105.
11. Ng SB, Lai KW, Murugaya S, Lee KM, Loong SL, Fook-Chong S, Tao M and Sng I. Nasal-type extranodal natural killer/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore. Mod Pathol 2004; 17: 1097-1107.
12. Aviles A, Diaz NR, Neri N, Cleto S and Talavera A. Angiocentric nasal T/natural killer cell lymphoma: a single centre study of prognostic factors in 108 patients. Clin Lab Haematol 2000; 22: 215-220.
13. Cheung MM, Chan JK, Lau WH, Ngan RK and Foo WW. Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 2002; 54: 182-190.
14. Beltran B, Quinones P, Morales D, Cotrina E and Castillo JJ. Different prognostic factors for survival in acute and lymphomatous adult Tcell leukemia/lymphoma. Leuk Res 2011; 35: 334-339.
15. Park BB, Ryoo BY, Lee JH, Kwon HC, Yang SH, Kang HJ, Kim HJ, Oh SY, Ko YH, Huh JR, Lee SS, Nam EM, Park KW, Kim JH, Kang JH, Bang SM, Park S, Kim K, Park K, Suh C and Kim WS. Clinical features and treatment outcomes of angioimmunoblastic T-cell lymphoma. Leuk Lymphoma 2007; 48: 716-722.
16. Rodriguez J, Conde E, Gutierrez A, Arranz R, Leon A, Marin J, Bendandi M, Albo C and Caballero MD. The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience. Ann Oncol 2007; 18: 652-657.
17. Kim SJ, Kim BS, Choi CW, Choi J, Kim I, Lee YH and Kim JS. Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type. Ann Oncol 2007; 18: 1382-1387.
18. Bossard C, Belhadj K, Reyes F, Martin-Garcia N, Berger F, Kummer JA, Briere J, Baglin AC, Cheze S, Bosq J, Ribrag V, Gisselbrecht C, Mounier N and Gaulard P. Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood 2007; 109: 2183-2189.
19. Kim WY, Jeon YK, Kim TM, Kim JE, Kim YA, Lee SH, Kim DW, Heo DS and Kim CW. Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma. Ann Oncol 2009; 20: 1688-1696.
20. Shim SJ, Yang WI, Shin E, Koom WS, Kim YB, Cho JH, Suh CO, Kim JH and Kim GE. Clinical significance of cyclooxygenase-2 expression in extranodal natural killer (NK)/T-cell lymphoma, nasal type. Int J Radiat Oncol Biol Phys 2007; 67: 31-38.
21. Ham MF and Ko YH. Natural killer cell neoplasm: biology and pathology. Int J Hematol 2010; 92: 681-689.
22. Chiarle R, Podda A, Prolla G, Gong J, Thorbecke GJ and Inghirami G. CD30 in normal and neoplastic cells. Clin Immunol 1999; 90: 157-164.
23. Horie R and Watanabe T. CD30: expression and function in health and disease. Semin Immunol 1998; 10: 457-470.
24. Gaal K, Sun NC, Hernandez AM and Arber DA. Sinonasal NK/T-cell lymphomas in the United States. Am J Surg Pathol 2000; 24: 1511-1517.
25. Ko YH, Ree HJ, Kim WS, Choi WH, Moon WS and Kim SW. Clinicopathologic and genotypic study of extranodal nasal-type natural killer/Tcell lymphoma and natural killer precursor lymphoma among Koreans. Cancer 2000; 89: 2106-2116.
26. Li T, Zhang B, Ye Y and Yin H. Immunohistochemical and genetic analysis of Chinese nasal natural killer/T-cell lymphomas. Hum Pathol 2006; 37: 54-60.
27. Lu D, Lin CN, Chuang SS, Hwang WS and Huang WT. T-cell and NK/T-cell lymphomas in southern Taiwan: a study of 72 cases in a single institute. Leuk Lymphoma 2004; 45: 923-928.
28. Schwartz EJ, Molina-Kirsch H, Zhao S, Marinelli RJ, Warnke RA and Natkunam Y. Immunohistochemical characterization of nasal-type extranodal NK/T-cell lymphoma using a tissue microarray: an analysis of 84 cases. Am J Clin Pathol 2008; 130: 343-351.
29. Mraz-Gernhard S, Natkunam Y, Hoppe RT, LeBoit P, Kohler S and Kim YH. Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course. J Clin Oncol 2001; 19: 2179-2188.
30. Takahara M, Kishibe K, Bandoh N, Nonaka S and Harabuchi Y. P53, N- and K-Ras, and betacatenin gene mutations and prognostic factors in nasal NK/T-cell lymphoma from Hokkaido, Japan. Hum Pathol 2004; 35: 86-95.